Amgen 대차 대조표 상태
재무 상태 기준 확인 1/6
Amgen 의 총 주주 지분은 $7.5B 이고 총 부채는 $60.4B, 이는 부채 대 자기자본 비율을 802.4% 로 가져옵니다. 총자산과 총부채는 각각 $90.9B 및 $83.4B 입니다. Amgen 의 EBIT는 $6.7B 이며 이자보상배율은 2.1 입니다. $9.0B 의 현금 및 단기 투자금을 보유하고 있습니다.
주요 정보
802.4%
부채 비율
US$60.40b
부채
| 이자 보상 비율 | 2.1x |
| 현금 | US$9.01b |
| 주식 | US$7.53b |
| 총 부채 | US$83.36b |
| 총 자산 | US$90.88b |
최근 재무 상태 업데이트
Amgen (NASDAQ:AMGN) Takes On Some Risk With Its Use Of Debt
Jul 26
Is Amgen (NASDAQ:AMGN) Using Too Much Debt?
Apr 01Is Amgen (NASDAQ:AMGN) A Risky Investment?
Dec 28Is Amgen (NASDAQ:AMGN) Using Too Much Debt?
Sep 22Recent updates
Amgen: A Biotech Giant Offering Value And Growth In A Frothy Market
Nov 03Amgen Inc. Beat Analyst Estimates: See What The Consensus Is Forecasting For Next Year
Nov 02Amgen Q3 Earnings Review: So Many Questions, But MariTide Data Top Of The List
Oct 25Amgen: Pipeline Updates, Uplizna Performs And Rocatinlimab Underwhelms
Sep 26Amgen: Growth Is Still A Better Choice
Aug 28Amgen Inc. Just Missed EPS By 46%: Here's What Analysts Think Will Happen Next
Aug 09Amgen: Shows Why Dividend Investing Is Getting Tougher
Aug 07Amgen (NASDAQ:AMGN) Takes On Some Risk With Its Use Of Debt
Jul 26The Price Is Right For Amgen Inc. (NASDAQ:AMGN)
Jul 11Amgen: An Emerging GLP-1 Play, Modest Mid-Teens P/E With Strong Momentum
Jul 05Amgen: You Haven't Seen Anything Yet
Jun 17Amgen Is A Fantastic Dividend Growth Stock With A Weight-Loss Wild Card
Jun 04Amgen Stock: Poised To Break Out (Technical Analysis)
May 21Is Amgen Inc. (NASDAQ:AMGN) Trading At A 41% Discount?
May 04Amgen Stock: Recent Weakness Is Not A Buying Opportunity Yet
May 01Amgen: The Giant With An Impressive Pipeline
Apr 15Is Amgen (NASDAQ:AMGN) Using Too Much Debt?
Apr 01Move Over Eli Lilly: Amgen Could Be The Next Obesity Wonder Stock
Mar 31Amgen Will Benefit From Increased Medical Spending
Mar 12Amgen: A Good Dividend Growth Stock For The Watch List
Mar 04Amgen's (NASDAQ:AMGN) Shareholders May Want To Dig Deeper Than Statutory Profit
Feb 21Pinning Down Amgen Inc.'s (NASDAQ:AMGN) P/E Is Difficult Right Now
Feb 16Amgen: Weight Loss Drug Candidate Debate A Red Herring - Buying The Dip Advisable
Feb 08Amgen: Accelerating The Business And Dividend Growth
Jan 29Is Amgen Inc. (NASDAQ:AMGN) Trading At A 44% Discount?
Jan 29Up 40%, 3%-Yielding Amgen Is Still One Of My Favorite Healthcare Stocks
Jan 22Is Amgen (NASDAQ:AMGN) A Risky Investment?
Dec 28Here's Why Amgen (NASDAQ:AMGN) Has Caught The Eye Of Investors
Dec 13Are Investors Undervaluing Amgen Inc. (NASDAQ:AMGN) By 46%?
Oct 23Is Amgen (NASDAQ:AMGN) Using Too Much Debt?
Sep 22Do Amgen's (NASDAQ:AMGN) Earnings Warrant Your Attention?
Sep 04재무 상태 분석
단기부채: AMGN 의 단기 자산 ( $26.8B )이 단기 부채( $20.3B ).
장기 부채: AMGN 의 단기 자산( $26.8B )은 장기 부채( $63.0B ).
부채 대 자본 내역 및 분석
부채 수준: AMGN 의 순부채 대 자기자본 비율( 682.7% )은 높음으로 간주됩니다.
부채 감소: AMGN 의 부채 대 자기자본 비율은 지난 5년간 272.6% 에서 802.4% 로 증가했습니다.
부채 범위: AMGN 의 부채는 영업 현금 흐름 ( 12% )에 의해 잘 갚지 않음입니다.
이자 보장: AMGN 의 부채에 대한 이자 지급은 EBIT( 2.1 x 적용 범위)만큼 잘 덮이지 않음입니다.